Nishimura et al. demonstrated sandwich RNAi inhibition by targeting the important ovarian cancer oncogene, EphA2, using a combination of EphA2-targeting siRNAs and miR-520d-3p (an EphA2-targeting miRNA) mimics. Here, EPHA2 is linked to ovarian carcinoma.